C. McAdam-Marx

发表

The societal costs of low back pain: data published between 2001 and 2007.

Carrie McAdam-Marx, J. Fritz, C. Asche, 2007, Journal of pain & palliative care pharmacotherapy.

Exenatide: Review of its Role as Adjunctive Therapy in Patients with Type 2 Diabetes

C. McAdam-Marx, B. Bellows, E. Hunter, 2011 .

Contemporary management of patients with Type 2 diabetes

C. McAdam-Marx, D. Brixner, B. Bellows, 2010, Expert review of cardiovascular therapy.

Application of electronic medical record data for health outcomes research: a review of recent literature

Carrie McAdam-Marx, C. McAdam-Marx, J. Biskupiak, 2013, Expert review of pharmacoeconomics & outcomes research.

SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives

C. McAdam-Marx, K. White, Holly E. Gurgle, 2016, Vascular health and risk management.

Comparing Medication Adherence Methods in Lipid-Modifying Therapy

C. McAdam-Marx, J. LaFleur, J. Lyon, 2012 .

Real-World Evidence in Pain Research: A Review of Data Sources

C. McAdam-Marx, B. Bellows, E. Biltaji, 2014, Journal of pain & palliative care pharmacotherapy.

Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.

C. Mullins, B. Seal, C. Asche, 2008, The Journal of antimicrobial chemotherapy.

Comparison of low-dose liraglutide use versus other GLP-1 receptor agonists in patients without type 2 diabetes.

S. Farahbakhshian, C. McAdam-Marx, E. Wittbrodt, 2017, The American journal of managed care.

Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data.

U. Iloeje, C. McAdam-Marx, D. Brixner, 2014, Diabetes research and clinical practice.

Postmenopausal osteoporosis: Current and future treatment options

C. Asche, C. Kirkness, C. McAdam-Marx, 2007 .

Pharmacist-provided diabetes management and education via a telemonitoring program.

L. Lenert, C. McAdam-Marx, L. Shane-McWhorter, 2015, Journal of the American Pharmacists Association : JAPhA.

Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record data

S. Silverman, J. Nebeker, C. Asche, 2011, Journal of Bone and Mineral Metabolism.

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA

M. Jhaveri, C. Asche, C. McAdam-Marx, 2009, Osteoporosis International.

Team-based approach to addressing simvastatin safety concerns.

C. McAdam-Marx, Karly A. Pippitt, K. Gunning, 2013, Journal of the American Pharmacists Association : JAPhA.

Characterization of Patients Undergoing Total Knee Arthroplasty in a Real-World Setting and Pain-Related Medication Prescriptions for Management of Postoperative Pain

C. Asche, C. Kirkness, C. McAdam-Marx, 2012, Journal of pain & palliative care pharmacotherapy.

Patent extension policy for paediatric indications

Benjamin Campbell, R. Nelson, C. McAdam-Marx, 2011, Applied health economics and health policy.

The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.

C. McAdam-Marx, N. Ruiz‐Negrón, Jane M. Sullivan, 2022, Journal of managed care & specialty pharmacy.

Systematic review on quality control for drug management programs: Is quality reported in the literature?

A. Holtorf, C. McAdam-Marx, D. Schaaf, 2009, BMC health services research.

Improving Diabetes Care in Underserved Patients through a ?Learning Your Abcs? Education And Screening Program

C. McAdam-Marx, Arati Dahal, Bonnie E. Stout, 2015 .

Once-weekly exenatide as a treatment for Type 2 diabetes

C. McAdam-Marx, Holly E. Gurgle, Marisa B. Schauerhamer, 2015, Expert review of cardiovascular therapy.

Healthcare costs and resource utilization associated with renal cell carcinoma among older Americans: A longitudinal case-control study using the SEER-Medicare data.

S. Ounpraseuth, N. Payakachat, J. Tilford, 2022, Urologic oncology.

Augmenting Telemonitoring Interventions by Targeting Patient Needs in a Primarily Hispanic Underserved Population

L. Lenert, C. McAdam-Marx, L. Shane-McWhorter, 2016, Diabetes Spectrum.

The determinants of antihypertensive use and expenditure in patients with hypertension in the USA

C. McAdam-Marx, B. Cai, 2014 .

Comparative effectiveness of once‐weekly glucagon‐like peptide‐1 receptor agonists with regard to 6‐month glycaemic control and weight outcomes in patients with type 2 diabetes

C. McAdam-Marx, E. Wittbrodt, S. Unni, 2018, Diabetes, obesity & metabolism.

Real-World Glycemic Control from GLP-1RA Therapy with and Without Concurrent Insulin in Patients with Type 2 Diabetes.

C. McAdam-Marx, Hiep Nguyen, S. Unni, 2017, Journal of managed care & specialty pharmacy.

Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis.

C. McAdam-Marx, Hiep Nguyen, S. Unni, 2016, Clinical therapeutics.

Elective Endovascular Aortic Aneurysm Repair Continues to Cost More than Open Abdominal Aortic Aneurysm Repair.

L. Kraiss, C. McAdam-Marx, M. Humphries, 2017, Annals of vascular surgery.

All-Cause and Incremental Per Patient Per Year Cost Associated with Chronic Hepatitis C Virus and Associated Liver Complications in the United States: A Managed Care Perspective

C. McAdam-Marx, D. Brixner, J. Biskupiak, 2011, Journal of managed care pharmacy : JMCP.

Characterization of Patients Undergoing Total Hip Arthroplasty in a Real-World Setting and Pain-Related Medication Prescriptions for Management of Postoperative Pain

C. Asche, C. Kirkness, C. McAdam-Marx, 2012, Journal of pain & palliative care pharmacotherapy.

Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.

C. McAdam-Marx, D. Brixner, X. Ye, 2009, Clinical therapeutics.

Problems in studying the association between race and pain in outcomes research.

C. McAdam-Marx, K. Jackson, J. LaFleur, 2007, Journal of pain & palliative care pharmacotherapy.

Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting

Melissa S. Briley, C. McAdam-Marx, C. Tak, 2019, BMC Health Services Research.

Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United States.

D. Klepser, C. McAdam-Marx, Jiayu Cui, 2021, Journal of managed care & specialty pharmacy.

Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study)

J. Liberman, U. Iloeje, F. Bloom, 2014, International journal of clinical practice.

Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.

C. McAdam-Marx, D. Brixner, B. Bellows, 2014, Journal of managed care & specialty pharmacy.

Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog

Carrie McAdam-Marx, C. McAdam-Marx, Jason Young, 2010, Clinical medicine insights. Endocrinology and diabetes.

Economic implications with newer agents to reduce cardiovascular risk in diabetes.

C. McAdam-Marx, 2018, The American journal of managed care.

Clinical Risk Factors for Fracture in Postmenopausal Osteoporotic Women: A Review of the Recent Literature

C. Kirkness, C. McAdam-Marx, D. Brixner, 2008, The Annals of pharmacotherapy.

Physician utilization by insurance type among youth with type 2 diabetes.

R. Field, C. McAdam-Marx, S. Moelter, 2010, The American journal of managed care.

Effect of Medicare Reimbursement Reduction for Imaging Services on Osteoporosis Screening Rates

C. McAdam-Marx, S. Unni, X. Ye, 2012, Journal of the American Geriatrics Society.

Achievement of Adequate Glycemic Control in Patients With Type 2 Diabetes and Comorbid Mental Health Conditions Treated in a Primary Care Setting

C. McAdam-Marx, Katherine T. Fortenberry, L. Gren, 2017, Diabetes Spectrum.

Changes in health-related quality of life outcomes in older patients with kidney cancer: A longitudinal cohort analysis with matched controls.

S. Ounpraseuth, N. Payakachat, J. Tilford, 2020, Urologic oncology.

Association of Health-Related Quality of Life with Overall Survival in Older Americans with Kidney Cancer: A Population-Based Cohort Study

S. Ounpraseuth, N. Payakachat, J. Tilford, 2021, Healthcare.

Costs of Opioid Abuse and Misuse Determined From a Medicaid Database

C. McAdam-Marx, J. Cleveland, C. Roland, 2010, Journal of pain & palliative care pharmacotherapy.

Cost and Comorbidities Associated with Opioid Abuse in Managed Care and Medicaid Patients in the United States: A Comparison of Two Recently Published Studies

C. McAdam-Marx, S. Haroutiunian, S. Ghate, 2010, Journal of pain & palliative care pharmacotherapy.

Perceptions of prior authorization by use of electronic prior authorization software: A survey of providers in the United States.

C. McAdam-Marx, L. Scheier, Brandon Helding, 2022, Journal of managed care & specialty pharmacy.

Cost-effectiveness of insulin analogs.

C. McAdam-Marx, D. Brixner, 2008, The American journal of managed care.

Association between oral antidiabetic use, adverse events and outcomes in patients with type 2 diabetes

C. McAdam-Marx, X. Sheng, C. Plauschinat, 2008, Diabetes, obesity & metabolism.

Telemedicine and health access inequalities during the COVID-19 pandemic

C. McAdam-Marx, K. Samson, Leslie A Eiland, 2022, Journal of global health.

Evaluation of Adverse Events of Oral Antihyperglycaemic Monotherapy Experienced by a Geriatric Population in a Real-World Setting

C. Asche, C. McAdam-Marx, X. Sheng, 2008, Drugs & aging.

Role Of Glycemic Control In Development Of Atrial Fibrillation In Patients With Type 2 Diabetes Mellitus

R. Nelson, C. McAdam-Marx, D. Witt, 2016 .

Impact of statin guidelines on statin utilization and costs in an employer-based primary care clinic.

C. McAdam-Marx, Holly E. Gurgle, Marisa B. Schauerhamer, 2017, The American journal of managed care.

The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.

C. McAdam-Marx, Arati Dahal, K. Gunning, 2015, Journal of managed care & specialty pharmacy.

Using projective exercises to identify patient perspectives of living with comorbid type 2 diabetes and asthma

M. Feehan, Nancy A. Allen, C. McAdam-Marx, 2019, Chronic illness.

The Utah Remote Monitoring Project: improving health care one patient at a time.

L. Lenert, C. McAdam-Marx, L. Shane-McWhorter, 2014, Diabetes technology & therapeutics.

Analysis of glycaemic control and weight change in patients initiated with human or analog insulin in an US ambulatory care setting

C. McAdam-Marx, D. Brixner, M. Aagren, 2010, Diabetes, obesity & metabolism.

Problems in Studying the Association Between Race and Pain in Outcomes Research

C. McAdam-Marx, K. Jackson, J. LaFleur, 2007 .

Association Between Cardiometabolic Risk Factors and Body Mass Index Based on Diagnosis and Treatment Codes in an Electronic Medical Record Database

C. McAdam-Marx, D. Brixner, R. Ben-Joseph, 2008, Journal of managed care pharmacy : JMCP.

Six‐month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting

K. Boye, C. McAdam-Marx, D. Brixner, 2009, Diabetes, obesity & metabolism.

In-Person and Telehealth Provider Access and Glycemic Control for People With Diabetes During the COVID-19 Pandemic

C. McAdam-Marx, K. Samson, Leslie A Eiland, 2023, Journal of Diabetes Science and Technology.

The effects of patient out-of-pocket costs on insulin use among people with type 1 and type 2 diabetes with Medicare Advantage insurance-2014-2018.

C. McAdam-Marx, N. Ruiz‐Negrón, J. Sullivan, 2023, Health services research.

Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.

C. McAdam-Marx, B. Bellows, R. Bailey, 2019, Journal of managed care & specialty pharmacy.

Managed Care Pharmacy Research on Inappropriate Opioid Use Interventions

C. McAdam-Marx, L. Happe, Lt Lauren Hertzog, 2020, Journal of managed care & specialty pharmacy.

Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin

C. McAdam-Marx, D. Brixner, M. Aagren, 2010, Current medical research and opinion.

Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes

C. McAdam-Marx, Kibum Kim, D. Brixner, 2019, Diabetes, obesity & metabolism.

Long-Term Impact of an Electronic Health Record-Enabled, Team-Based, and Scalable Population Health Strategy Based on the Chronic Care Model

Kensaku Kawamoto, John B. Anderson, Kevin J. Anstrom, 2016, AMIA.

Application of electronic medical record data for health outcomes research: a review of recent literature

C. McAdam-Marx, J. Biskupiak, Junji Lin, 2013, Expert review of pharmacoeconomics & outcomes research.

Identification of Medication Related Problems During Medication Reviewsin A Community Setting

C. McAdam-Marx, Br, Marisa B. Schauerhamer, 2015 .

Patent extension policy for paediatric indications

Benjamin Campbell, R. Nelson, C. McAdam-Marx, 2011, Applied health economics and health policy.

Once-weekly exenatide as a treatment for Type 2 diabetes

C. McAdam-Marx, Holly E. Gurgle, Marisa B. Schauerhamer, 2015, Expert review of cardiovascular therapy.

Pharmacist-provided diabetes management and education via a telemonitoring program.

L. Lenert, C. McAdam-Marx, Marta Petersen, 2015, Journal of the American Pharmacists Association : JAPhA.